Basel Medical Group Ltd
BMGL
$0.61
$0.024.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.97M | -3.83M | -118.90K | -120.20K | 275.70K |
| Total Depreciation and Amortization | 319.10K | 307.70K | 131.80K | 133.30K | 97.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.09M | 3.94M | -95.10K | -96.10K | -94.20K |
| Change in Net Operating Assets | -533.50K | -514.30K | -1.34M | -1.35M | 595.00K |
| Cash from Operations | -97.60K | -94.10K | -1.42M | -1.44M | 873.80K |
| Capital Expenditure | -4.18M | -4.03M | -6.90K | -7.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.90K | -20.20K | 20.40K | 20.60K | -- |
| Cash from Investing | -4.21M | -4.05M | 13.50K | 13.60K | 0.00 |
| Total Debt Issued | 5.14M | 5.14M | 2.21M | 2.21M | 482.70K |
| Total Debt Repaid | -2.14M | -2.14M | -2.71M | -2.71M | -682.00K |
| Issuance of Common Stock | 4.88M | 4.88M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.26M | -4.26M | 5.13M | 5.13M | -479.70K |
| Cash from Financing | 2.78M | 2.68M | 3.47M | 3.51M | -501.70K |
| Foreign Exchange rate Adjustments | -173.70K | -167.50K | -4.50K | -4.60K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.69M | -1.63M | 2.06M | 2.08M | 372.20K |